Drug shown to be successful in treating autoimmune blood disease
Patients receiving efgartigimod, a drug being studied for the treatment of chronic primary immune thrombocytopenia (ITP), had a much greater increase in platelet counts, which are essential for clotting and stopping bleeding, in contrast to those receiving ...
13 December, 2022
Read more